Current insights and future directions of LncRNA Morrbid in disease pathogenesis

被引：0

作者：

Yang, Haiqiong ^{[1
,2
,3
]}

Gao, Jiali ^{[4
,5
]}

Zheng, Zaiyong ^{[1
,2
,3
]}

Yu, Yang ^{[1
,2
,3
]}

Zhang, Chunxiang ^{[1
,2
,3
]}

机构：

[1] Southwest Med Univ, Affiliated Hosp, Dept Cardiol, Luzhou, Peoples R China

[2] Southwest Med Univ, Inst Cardiovasc Res, Key Lab Med Electrophysiol, Minist Educ, Luzhou, Peoples R China

[3] Southwest Med Univ, Inst Cardiovasc Res, Collaborat Innovat Ctr Prevent Cardiovasc Dis, Med Electrophysiol Key Lab Sichuan Prov, Luzhou, Peoples R China

[4] Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China

[5] Luzhou Peoples Hosp, Dept Pharm, Luzhou, Peoples R China

来源：

HELIYON | 2024年 / 10卷 / 17期

基金：

中国国家自然科学基金;

关键词：

Long non-coding RNA; LncRNA Morrbid; MIR4435-2HG; Tumor; Cardiovascular disease; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; MIR4435-2HG; PROGRESSION; INHIBITION; MICROENVIRONMENT; IDENTIFICATION; PROLIFERATION; METASTASIS; MIGRATION;

D O I：

10.1016/j.heliyon.2024.e36681

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Non-coding RNAs have emerged as important regulators of gene expression and contributors to many diseases. LncRNA Morrbid, a long non-coding RNA, has been widely studied in recent years. Current literature reports that lncRNA Morrbid is involved in various diseases such as tumors, cardiovascular diseases, inflammatory diseases and metabolic disorder. However, controversial conclusions exist in current studies. As a potential therapeutic target, it is necessary to comprehensively review the current evidence. In this work, we carefully review the literature on Morrbid and discuss each of the hot topics related to lncRNA Morrbid.

引用

页数：11

共 50 条

[41] Mobile Health Technologies for Older Adults with Cardiovascular Disease: Current Evidence and Future Directions
Ryan P. Searcy
Jenny Summapund
Deborah Estrin
John P. Pollak
Antoinette Schoenthaler
Andrea B. Troxel
John A. Dodson
Current Geriatrics Reports, 2019, 8 : 31 - 42
[42] Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
Khera, Rohan
Valero-Elizondo, Javier
Nasir, Khurram
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
[43] Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk
Dwiputra, Bambang
Santoso, Anwar
Purwowiyoto, Budhi Setianto
Radi, Basuni
Pandhita, Bashar Adi Wahyu
Fatrin, Serlie
Ambari, Ade Meidian
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2024, 33 (01) : 1 - 7
[44] Mobile Health Technologies for Older Adults with Cardiovascular Disease: Current Evidence and Future Directions
Searcy, Ryan P.
Summapund, Jenny
Estrin, Deborah
Pollak, John P.
Schoenthaler, Antoinette
Troxel, Andrea B.
Dodson, John A.
CURRENT GERIATRICS REPORTS, 2019, 8 (01) : 31 - 42
[45] The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease
Tiew, Pei Yee
Mac Aogain, Micheal
Chotirmall, Sanjay H.
CURRENT OPINION IN PULMONARY MEDICINE, 2022, 28 (02) : 121 - 133
[46] Current approaches and future directions in the management of pterygium
Kyoung Woo Kim
Jae Chan Kim
International Journal of Ophthalmology, 2018, (05) : 709 - 711
[47] Wound dressings: Current advances and future directions
Ghomi, Erfan Rezvani
Khalili, Shahla
Khorasani, Saied Nouri
Neisiany, Rasoul Esmaeely
Ramakrishna, Seeram
JOURNAL OF APPLIED POLYMER SCIENCE, 2019, 136 (27)
[48] Homoharringtonine - History, current research, and future directions
Kantarjian, HM
Talpaz, M
Santini, V
Murgo, A
Cheson, B
O'Brien, SM
CANCER, 2001, 92 (06) : 1591 - 1605
[49] Cancer metabolism: current perspectives and future directions
Munoz-Pinedo, C.
El Mjiyad, N.
Ricci, J-E
CELL DEATH & DISEASE, 2012, 3 : e248 - e248
[50] Current approaches and future directions in the management of pterygium
Kim, Kyoung Woo
Kim, Jae Chan
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (05) : 709 - 711

← 1 2 3 4 5 →